Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Patrick Wingrove

Daily weight loss pill achieves main goal in late-stage trial

An experimental GLP-1 pill has helped overweight adults with type 2 diabetes shed 10.5 per cent of body weight in a late-stage trial.

Eli Lilly confirmed the results on Tuesday after data from an earlier study of the drug in patients without diabetes sent company shares tumbling.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.